Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
life sciences
national blog main
san francisco top stories
boston blog main
clinical trials
gene therapy
national
national top stories
new york top stories
san diego blog main
san diego top stories
san francisco blog main
3d imaging
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
billy dunn
biogen
biomarin pharmaceutical
biotech
bluebird bio
boston top stories
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
chronic care act
competitive generic therapy
cystic fibrosis
deals
detroit blog main
detroit top stories
devices
drug prices
drug pricing
entrepreneurship
What
drug
3
×
patients
3
×
therapy
3
×
developers
fda
approved
aren’t
atrophy
bio
daily
daunting
drugs
evrysdi
firms
friday
gene
green
healthcare
help
home
imminent
intended
lights
liquid
long
markets
maze
medicare
medicine
mindmaze
moves
muscular
new
news
noteworthy
oral
physical
policies
present
prices
Language
unset
Current search:
fda
×
drug
×
therapy
×
patients
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets